Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Indocyanine Green Guided Identification of Sentinel Lymph Nodes Via Mastectomy Incision in Breast Cancer Patients (INIGMA Study)

NCT07362485 is registered in ClinicalTrials.gov with Isabelle Henskens as lead sponsor.

NCT NCT07362485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07362485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Indocyanine Green Guided Identification of Sentinel Lymph Nodes Via Mastectomy Incision in Breast Cancer Patients (INIGMA Study)
Lead sponsor
Isabelle Henskens
Phase
Not applicable
Overall status
Recruiting
Start date
August 22, 2022
Completion date
June 30, 2026
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, fluorescence imaging, indocyanine green (icg), lymph node mapping, lymphatic metastasis, mastectomy, radioisotopes, sentinel lymph node, sentinel lymph node biopsy (slnb), sentinel lymph node detection